Wockhardt receives ‘EU GMP Certificate’ by competent authority, Berlin

06 Jan 2017 Evaluate

Wockhardt has been issued EU GMP Certificate by the competent authority, Berlin, Germany confirming that the company’s manufacturing facility at 138, GIDC Estate, Ankaleshwar, Gujarat, complies with the principles and guidelines of Good Manufacturing Practices. The certificate issued in this regard is valid for 3 years.

Earlier, the US Food and Drug Administration (USFDA) has recently issued a warning letter to Wockhardt’s Ankleshwar plant for data integrity issues, destruction of records and other violation of good manufacturing practices.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.




Wockhardt Share Price

1415.10 -30.80 (-2.13%)
01-Jan-2026 14:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1250.85
Cipla 1499.55
Zydus Lifesciences 912.55
Lupin 2101.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×